1. Home
  2. KITTW vs WGSWW Comparison

KITTW vs WGSWW Comparison

Compare KITTW & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITTW

Nauticus Robotics Inc.

N/A

Current Price

$0.05

Market Cap

0.0

Sector

Industrials

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

N/A

Current Price

$0.01

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KITTW
WGSWW
Founded
N/A
2017
Country
United States
United States
Employees
47
1300
Industry
Industrial Machinery/Components
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
KITTW
WGSWW
Price
$0.05
$0.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.3K
106.4K
Earning Date
N/A
02-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$305,450,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.79
52 Week Low
$0.02
$0.00
52 Week High
$0.15
$0.23

Technical Indicators

Market Signals
Indicator
KITTW
WGSWW
Relative Strength Index (RSI) 44.00 43.08
Support Level $0.04 $0.01
Resistance Level $0.07 $0.02
Average True Range (ATR) 0.01 0.00
MACD -0.00 0.00
Stochastic Oscillator 7.56 31.01

Price Performance

Historical Comparison
KITTW
WGSWW

About KITTW Nauticus Robotics Inc.

Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: